{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:08:38Z","timestamp":1762898918073},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Inhibitor of differentiation 4 (Id4), a member of the helix-loop-helix family of transcriptional regulators has emerged as a tumor suppressor in prostate cancer. Id4 is expressed in the normal prostate where its expression is also regulated by androgens. In this study we investigated the effect of loss of Id4 (Id4-\/-) on adult prostate morphology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Histological analysis was performed on prostates from 6-8\u00a0weeks old Id4-\/-, Id4+\/- and Id4+\/+ mice. Expression of Id1, Sox9, Myc, androgen receptor, Akt, p-Akt, Pten and Nkx3.1 was investigated by immunohistochemistry. Androgen receptor binding on NKX3.1 promoter was studied by chromatin immuno-precipitation. Id4 was either over-expressed or silenced in prostate cancer cell lines DU145 and LNCaP respectively followed by analysis of PTEN, NKX3.1 and Sox9 expression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Id4-\/- mice had smaller prostates with fewer tubules, smaller tubule diameters and subtle mPIN like lesions. Levels of androgen receptor were similar between wild type and Id4-\/- prostate. Decreased NKX3.1 expression was in part due to decreased androgen receptor binding on NKX3.1 promoter in Id4-\/- mice. The increase in the expression of Myc, Sox9, Id1, Ki67 and decrease in the expression of PTEN, Akt and phospho-AKT was associated with subtle mPIN like lesions in Id4-\/- prostates. Finally, prostate cancer cell line models in which Id4 was either silenced or over-expressed confirmed that Id4 regulates NKX3.1, Sox9 and PTEN.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results suggest that loss of Id4 attenuates normal prostate development and promotes hyperplasia\/dysplasia with subtle mPIN like lesions characterized by gain of Myc and Id1 and loss of Nkx3.1 and Pten expression. One of the mechanisms by which Id4 may regulate normal prostate development is through regulating androgen receptor binding to respective response elements such as those on NKX3.1 promoter. In spite of these complex alterations, large neoplastic lesions in Id4-\/- prostates were not observed suggesting the possibility of mechanisms\/pathways such as loss of Akt that could restrain the formation of significant pre-cancerous lesions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-12-67","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T08:14:40Z","timestamp":1371802480000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN"],"prefix":"10.1186","volume":"12","author":[{"given":"Pankaj","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley Evans","family":"Knowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swathi","family":"Chinaranagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shravan","family":"Komaragiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peri","family":"Nagappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew C","family":"Havrda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaideep","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,21]]},"reference":[{"key":"1129_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0962-8924(03)00147-8","volume":"13","author":"MB Ruzinova","year":"2003","unstructured":"Ruzinova MB, Benezra R: Id proteins in development, cell cycle and cancer. Trends Cell Biol. 2003, 13: 410-418. 10.1016\/S0962-8924(03)00147-8","journal-title":"Trends Cell Biol"},{"key":"1129_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0014-4827(03)00014-4","volume":"285","author":"JP Coppe","year":"2003","unstructured":"Coppe JP, Smith AP, Desprez PY: Id proteins in epithelial cells. Exp Cell Res. 2003, 285: 131-145. 10.1016\/S0014-4827(03)00014-4","journal-title":"Exp Cell Res"},{"key":"1129_CR3","first-page":"58","volume":"8","author":"JD Norton","year":"1998","unstructured":"Norton JD, Deed RW, Craggs G, Sablitzky F: Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 1998, 8: 58-65.","journal-title":"Trends Cell Biol"},{"key":"1129_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0065-230X(04)92004-0","volume":"92","author":"P de Candia","year":"2004","unstructured":"de Candia P, Benezra R, Solit DB: A role for Id proteins in mammary gland physiology and tumorigenesis. Adv Cancer Res. 2004, 92: 81-94.","journal-title":"Adv Cancer Res"},{"key":"1129_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bone.2011.09.049","volume":"50","author":"T Sakata-Goto","year":"2012","unstructured":"Sakata-Goto T, Takahashi K, Kiso H, Huang B, Tsukamoto H, Takemoto M, Hayashi T, Sugai M, Nakamura T, Yokota Y: Id2 controls chondrogenesis acting downstream of BMP signaling during maxillary morphogenesis. Bone. 2012, 50: 69-78. 10.1016\/j.bone.2011.09.049","journal-title":"Bone"},{"key":"1129_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1182\/blood-2009-11-255075","volume":"116","author":"H Li","year":"2010","unstructured":"Li H, Ji M, Klarmann KD, Keller JR: Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development. Blood. 2010, 116: 1060-1069. 10.1182\/blood-2009-11-255075","journal-title":"Blood"},{"key":"1129_CR7","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1002\/dvdy.22762","volume":"240","author":"MR Jongbloed","year":"2011","unstructured":"Jongbloed MR, Vicente-Steijn R, Douglas YL, Wisse LJ, Mori K, Yokota Y, Bartelings MM, Schalij MJ, Mahtab EA, Poelmann RE, Gittenberger-De Groot AC: Expression of Id2 in the second heart field and cardiac defects in Id2 knock-out mice. Dev Dyn. 2011, 240: 2561-2577. 10.1002\/dvdy.22762","journal-title":"Dev Dyn"},{"issue":"Pt 22","key":"1129_CR8","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1242\/jcs.113.22.3897","volume":"113","author":"JD Norton","year":"2000","unstructured":"Norton JD: ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci. 2000, 113 (Pt 22): 3897-3905.","journal-title":"J Cell Sci"},{"key":"1129_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.immuni.2004.08.013","volume":"21","author":"H Li","year":"2004","unstructured":"Li H, Dai M, Zhuang Y: A T cell intrinsic role of Id3 in a mouse model for primary Sjogren\u2019s syndrome. Immunity. 2004, 21: 551-560. 10.1016\/j.immuni.2004.08.013","journal-title":"Immunity"},{"key":"1129_CR10","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1128\/MCB.19.9.5969","volume":"19","author":"L Pan","year":"1999","unstructured":"Pan L, Sato S, Frederick JP, Sun XH, Zhuang Y: Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol Cell Biol. 1999, 19: 5969-5980.","journal-title":"Mol Cell Biol"},{"key":"1129_CR11","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.4049\/jimmunol.0804249","volume":"182","author":"I Ueda-Hayakawa","year":"2009","unstructured":"Ueda-Hayakawa I, Mahlios J, Zhuang Y: Id3 restricts the developmental potential of gamma delta lineage during thymopoiesis. J Immunol. 2009, 182: 5306-5316. 10.4049\/jimmunol.0804249","journal-title":"J Immunol"},{"key":"1129_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/44334","volume":"401","author":"D Lyden","year":"1999","unstructured":"Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R: Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 1999, 401: 670-677. 10.1038\/44334","journal-title":"Nature"},{"key":"1129_CR13","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1242\/dev.01430","volume":"131","author":"K Yun","year":"2004","unstructured":"Yun K, Mantani A, Garel S, Rubenstein J, Israel MA: Id4 regulates neural progenitor proliferation and differentiation in vivo. Development. 2004, 131: 5441-5448. 10.1242\/dev.01430","journal-title":"Development"},{"key":"1129_CR14","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1242\/dev.069203","volume":"138","author":"J Dong","year":"2011","unstructured":"Dong J, Huang S, Caikovski M, Ji S, McGrath A, Custorio MG, Creighton CJ, Maliakkal P, Bogoslovskaia E, Du Z: ID4 regulates mammary gland development by suppressing p38MAPK activity. Development. 2011, 138: 5247-5256. 10.1242\/dev.069203","journal-title":"Development"},{"key":"1129_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1095\/biolreprod.111.091330","volume":"85","author":"MJ Oatley","year":"2011","unstructured":"Oatley MJ, Kaucher AV, Racicot KE, Oatley JM: Inhibitor of DNA binding 4 is expressed selectively by single spermatogonia in the male germline and regulates the self-renewal of spermatogonial stem cells in mice. Biol Reprod. 2011, 85: 347-356. 10.1095\/biolreprod.111.091330","journal-title":"Biol Reprod"},{"key":"1129_CR16","doi-asserted-by":"publisher","first-page":"e1001019","DOI":"10.1371\/journal.pgen.1001019","volume":"6","author":"Y Tokuzawa","year":"2010","unstructured":"Tokuzawa Y, Yagi K, Yamashita Y, Nakachi Y, Nikaido I, Bono H, Ninomiya Y, Kanesaki-Yatsuka Y, Akita M, Motegi H: Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation. PLoS Genet. 2010, 6: e1001019- 10.1371\/journal.pgen.1001019","journal-title":"PLoS Genet"},{"key":"1129_CR17","doi-asserted-by":"publisher","first-page":"24164","DOI":"10.1074\/jbc.M110.128744","volume":"285","author":"JM Murad","year":"2010","unstructured":"Murad JM, Place CS, Ran C, Hekmatyar SK, Watson NP, Kauppinen RA, Israel MA: Inhibitor of DNA binding 4 (ID4) regulation of adipocyte differentiation and adipose tissue formation in mice. J Biol Chem. 2010, 285: 24164-24173. 10.1074\/jbc.M110.128744","journal-title":"J Biol Chem"},{"key":"1129_CR18","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/emboj\/19.9.1998","volume":"19","author":"T Kondo","year":"2000","unstructured":"Kondo T, Raff M: The Id4 HLH protein and the timing of oligodendrocyte differentiation. EMBO J. 2000, 19: 1998-2007. 10.1093\/emboj\/19.9.1998","journal-title":"EMBO J"},{"key":"1129_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng1521","volume":"37","author":"L Yu","year":"2005","unstructured":"Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu YZ, Raval A, Liu TH, Ding W, Mao C: Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat Genet. 2005, 37: 265-274. 10.1038\/ng1521","journal-title":"Nat Genet"},{"key":"1129_CR20","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1038\/sj.onc.1208538","volume":"24","author":"N Umetani","year":"2005","unstructured":"Umetani N, Mori T, Koyanagi K, Shinozaki M, Kim J, Giuliano AE, Hoon DS: Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene. 2005, 24: 4721-4727. 10.1038\/sj.onc.1208538","journal-title":"Oncogene"},{"key":"1129_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1471-2407-8-154","volume":"8","author":"E Noetzel","year":"2008","unstructured":"Noetzel E, Veeck J, Niederacher D, Galm O, Horn F, Hartmann A, Knuchel R, Dahl E: Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer. BMC Cancer. 2008, 8: 154- 10.1186\/1471-2407-8-154","journal-title":"BMC Cancer"},{"key":"1129_CR22","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1158\/1078-0432.CCR-04-0689","volume":"10","author":"N Umetani","year":"2004","unstructured":"Umetani N, Takeuchi H, Fujimoto A, Shinozaki M, Bilchik AJ, Hoon DS: Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Clin Cancer Res. 2004, 10: 7475-7483. 10.1158\/1078-0432.CCR-04-0689","journal-title":"Clin Cancer Res"},{"key":"1129_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1182\/blood-2010-05-284638","volume":"117","author":"SS Chen","year":"2011","unstructured":"Chen SS, Claus R, Lucas DM, Yu L, Qian J, Ruppert AS, West DA, Williams KE, Johnson AJ, Sablitzky F: Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood. 2011, 117: 862-871. 10.1182\/blood-2010-05-284638","journal-title":"Blood"},{"key":"1129_CR24","doi-asserted-by":"publisher","first-page":"6946","DOI":"10.1038\/sj.onc.1206799","volume":"22","author":"AS Chan","year":"2003","unstructured":"Chan AS, Tsui WY, Chen X, Chu KM, Chan TL, Li R, So S, Yuen ST, Leung SY: Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Oncogene. 2003, 22: 6946-6953. 10.1038\/sj.onc.1206799","journal-title":"Oncogene"},{"key":"1129_CR25","first-page":"994","volume":"88","author":"M Bellido","year":"2003","unstructured":"Bellido M, Aventin A, Lasa A, Estivill C, Carnicer MJ, Pons C, Matias-Guiu X, Bordes R, Baiget M, Sierra J, Nomdedeu JF: Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia. Haematologica. 2003, 88: 994-1001.","journal-title":"Haematologica"},{"key":"1129_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1182\/blood-2007-07-092015","volume":"111","author":"LJ Russell","year":"2008","unstructured":"Russell LJ, Akasaka T, Majid A, Sugimoto KJ, Loraine Karran E, Nagel I, Harder L, Claviez A, Gesk S, Moorman AV: t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood. 2008, 111: 387-391. 10.1182\/blood-2007-07-092015","journal-title":"Blood"},{"key":"1129_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1476-4598-4-16","volume":"4","author":"Q Wu","year":"2005","unstructured":"Wu Q, Hoffmann MJ, Hartmann FH, Schulz WA: Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer. Mol Cancer. 2005, 4: 16- 10.1186\/1476-4598-4-16","journal-title":"Mol Cancer"},{"key":"1129_CR28","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/S0002-9440(10)63604-8","volume":"163","author":"L Shan","year":"2003","unstructured":"Shan L, Yu M, Qiu C, Snyderwine EG: Id4 regulates mammary epithelial cell growth and differentiation and is overexpressed in rat mammary gland carcinomas. Am J Pathol. 2003, 163: 2495-2502. 10.1016\/S0002-9440(10)63604-8","journal-title":"Am J Pathol"},{"issue":"2","key":"1129_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/cam4.16","volume":"1","author":"P Sharma","year":"2012","unstructured":"Sharma P, Chinaranagari S, Patel D, Carey J, Chaudhary J: Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer. Cancer Med. 2012, 1 (2): 176-186. 10.1002\/cam4.16","journal-title":"Cancer Med"},{"key":"1129_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00345-011-0750-8","volume":"30","author":"A Vinarskaja","year":"2012","unstructured":"Vinarskaja A, Goering W, Ingenwerth M, Schulz WA: ID4 is frequently downregulated and partially hypermethylated in prostate cancer. World J Urol. 2012, 30: 319-325. 10.1007\/s00345-011-0750-8","journal-title":"World J Urol"},{"key":"1129_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12253-008-9096-y","volume":"15","author":"X Yu","year":"2009","unstructured":"Yu X, Xu X, Han B, Zhou R: Inhibitor of DNA binding-1 overexpression in prostate cancer: relevance to tumor differentiation. Pathol Oncol Res. 2009, 15: 91-96. 10.1007\/s12253-008-9096-y","journal-title":"Pathol Oncol Res"},{"key":"1129_CR32","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-03-0933","volume":"10","author":"JP Coppe","year":"2004","unstructured":"Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY: Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res. 2004, 10: 2044-2051. 10.1158\/1078-0432.CCR-03-0933","journal-title":"Clin Cancer Res"},{"key":"1129_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cam4.19","volume":"1","author":"P Sharma","year":"2012","unstructured":"Sharma P, Patel D, Chaudhary J: Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B. Cancer Med. 2012, 1: 187-197. 10.1002\/cam4.19","journal-title":"Cancer Med"},{"key":"1129_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/pros.20366","volume":"66","author":"AJ Asirvatham","year":"2006","unstructured":"Asirvatham AJ, Schmidt MA, Chaudhary J: Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells. Prostate. 2006, 66: 921-935. 10.1002\/pros.20366","journal-title":"Prostate"},{"key":"1129_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2407-9-173","volume":"9","author":"JP Carey","year":"2009","unstructured":"Carey JP, Asirvatham AJ, Galm O, Ghogomu TA, Chaudhary J: Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. BMC Cancer. 2009, 9: 173- 10.1186\/1471-2407-9-173","journal-title":"BMC Cancer"},{"key":"1129_CR36","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1158\/0008-5472.CAN-03-0946","volume":"64","author":"SB Shappell","year":"2004","unstructured":"Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R: Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res. 2004, 64: 2270-2305. 10.1158\/0008-5472.CAN-03-0946","journal-title":"Cancer Res"},{"key":"1129_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1476-4598-6-19","volume":"6","author":"J Gipp","year":"2007","unstructured":"Gipp J, Gu G, Crylen C, Kasper S, Bushman W: Hedgehog pathway activity in the LADY prostate tumor model. Mol Cancer. 2007, 6: 19- 10.1186\/1476-4598-6-19","journal-title":"Mol Cancer"},{"key":"1129_CR38","doi-asserted-by":"publisher","first-page":"31779","DOI":"10.1074\/jbc.271.50.31779","volume":"271","author":"CJ Bieberich","year":"1996","unstructured":"Bieberich CJ, Fujita K, He WW, Jay G: Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem. 1996, 271: 31779-31782. 10.1074\/jbc.271.50.31779","journal-title":"J Biol Chem"},{"key":"1129_CR39","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1101\/gad.13.8.966","volume":"13","author":"R DA Bhatia-Gaur","year":"1999","unstructured":"DA Bhatia-Gaur R, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Abate-Shen C, Shen MM: Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 1999, 13: 966-977. 10.1101\/gad.13.8.966","journal-title":"Genes Dev"},{"key":"1129_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3727\/105221611X12973615737622","volume":"15","author":"C Kojima","year":"2010","unstructured":"Kojima C, Zhang Y, Zimmer WE: Intronic DNA elements regulate androgen-dependent expression of the murine Nkx3.1 gene. Gene Expr. 2010, 15: 89-102.","journal-title":"Gene Expr"},{"key":"1129_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ccr.2006.03.031","volume":"9","author":"Q Lei","year":"2006","unstructured":"Lei Q, Jiao J, Xin L, Chang CJ, Wang S, Gao J, Gleave ME, Witte ON, Liu X, Wu H: NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell. 2006, 9: 367-378. 10.1016\/j.ccr.2006.03.031","journal-title":"Cancer Cell"},{"key":"1129_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1101\/sqb.2008.73.047","volume":"73","author":"H Zheng","year":"2008","unstructured":"Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z: Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harb Symp Quant Biol. 2008, 73: 427-437. 10.1101\/sqb.2008.73.047","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"1129_CR43","first-page":"3886","volume":"63","author":"C Abate-Shen","year":"2003","unstructured":"Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, Borowsky AD, Cardiff RD, Shen MM: Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res. 2003, 63: 3886-3890.","journal-title":"Cancer Res"},{"key":"1129_CR44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/030089169908500304","volume":"85","author":"MR Sollazzo","year":"1999","unstructured":"Sollazzo MR, Benassi MS, Magagnoli G, Gamberi G, Molendini L, Ragazzini P, Merli M, Ferrari C, Balladelli A, Picci P: Increased c-myc oncogene expression in Ewing\u2019s sarcoma: correlation with Ki67 proliferation index. Tumori. 1999, 85: 167-173.","journal-title":"Tumori"},{"key":"1129_CR45","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1089\/scd.2009.0093","volume":"19","author":"S Jung","year":"2010","unstructured":"Jung S, Park RH, Kim S, Jeon YJ, Ham DS, Jung MY, Kim SS, Lee YD, Park CH, Suh-Kim H: Id proteins facilitate self-renewal and proliferation of neural stem cells. Stem Cells Dev. 2010, 19: 831-841. 10.1089\/scd.2009.0093","journal-title":"Stem Cells Dev"},{"key":"1129_CR46","doi-asserted-by":"publisher","first-page":"e9427","DOI":"10.1371\/journal.pone.0009427","volume":"5","author":"T Iwata","year":"2010","unstructured":"Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL, Bethel C, Lotz MT, Yegnasubramanian S, Nelson WG: MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. PLoS One. 2010, 5: e9427- 10.1371\/journal.pone.0009427","journal-title":"PLoS One"},{"key":"1129_CR47","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1172\/JCI58540","volume":"122","author":"PD Anderson","year":"2012","unstructured":"Anderson PD, McKissic SA, Logan M, Roh M, Franco OE, Wang J, Doubinskaia I, van der Meer R, Hayward SW, Eischen CM: Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. J Clin Invest. 2012, 122: 1907-1919. 10.1172\/JCI58540","journal-title":"J Clin Invest"},{"key":"1129_CR48","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1073\/pnas.141235398","volume":"98","author":"RM Alani","year":"2001","unstructured":"Alani RM, Young AZ, Shifflett CB: Id1 regulation of cellular senescence through transcriptional repression of p16\/Ink4a. Proc Natl Acad Sci USA. 2001, 98: 7812-7816. 10.1073\/pnas.141235398","journal-title":"Proc Natl Acad Sci USA"},{"key":"1129_CR49","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1128\/MCB.17.10.5888","volume":"17","author":"S Prabhu","year":"1997","unstructured":"Prabhu S, Ignatova A, Park ST, Sun XH: Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol Cell Biol. 1997, 17: 5888-5896.","journal-title":"Mol Cell Biol"},{"key":"1129_CR50","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/pros.20633","volume":"67","author":"AJ Asirvatham","year":"2007","unstructured":"Asirvatham AJ, Carey JP, Chaudhary J: ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Prostate. 2007, 67: 1411-1420. 10.1002\/pros.20633","journal-title":"Prostate"},{"key":"1129_CR51","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1158\/0008-5472.CAN-09-2370","volume":"70","author":"MK Thomsen","year":"2010","unstructured":"Thomsen MK, Ambroisine L, Wynn S, Cheah KS, Foster CS, Fisher G, Berney DM, Moller H, Reuter VE, Scardino P: SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res. 2010, 70: 979-987. 10.1158\/0008-5472.CAN-09-2370","journal-title":"Cancer Res"},{"key":"1129_CR52","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1432-0436.2008.00293.x","volume":"76","author":"MK Thomsen","year":"2008","unstructured":"Thomsen MK, Francis JC, Swain A: The role of Sox9 in prostate development. Differentiation. 2008, 76: 728-735. 10.1111\/j.1432-0436.2008.00293.x","journal-title":"Differentiation"},{"key":"1129_CR53","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/0008-5472.CAN-07-5915","volume":"68","author":"H Wang","year":"2008","unstructured":"Wang H, Leav I, Ibaragi S, Wegner M, Hu GF, Lu ML, Balk SP, Yuan X: SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res. 2008, 68: 1625-1630. 10.1158\/0008-5472.CAN-07-5915","journal-title":"Cancer Res"},{"key":"1129_CR54","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997, 275: 1943-1947. 10.1126\/science.275.5308.1943","journal-title":"Science"},{"key":"1129_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/humupd\/dmq003","volume":"16","author":"KA Walters","year":"2010","unstructured":"Walters KA, Simanainen U, Handelsman DJ: Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Hum Reprod Update. 2010, 16: 543-558. 10.1093\/humupd\/dmq003","journal-title":"Hum Reprod Update"},{"key":"1129_CR56","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1210\/en.2006-1223","volume":"148","author":"U Simanainen","year":"2007","unstructured":"Simanainen U, Allan CM, Lim P, McPherson S, Jimenez M, Zajac JD, Davey RA, Handelsman DJ: Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function. Endocrinology. 2007, 148: 2264-2272. 10.1210\/en.2006-1223","journal-title":"Endocrinology"},{"key":"1129_CR57","doi-asserted-by":"publisher","first-page":"E1335","DOI":"10.1152\/ajpendo.00017.2009","volume":"296","author":"U Simanainen","year":"2009","unstructured":"Simanainen U, McNamara K, Gao YR, Handelsman DJ: Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation. Am J Physiol Endocrinol Metab. 2009, 296: E1335-E1343. 10.1152\/ajpendo.00017.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1129_CR58","doi-asserted-by":"publisher","first-page":"12679","DOI":"10.1073\/pnas.0704940104","volume":"104","author":"CT Wu","year":"2007","unstructured":"Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, Zhang C, Niu Y, Tsai MY, Chang C: Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci U S A. 2007, 104: 12679-12684. 10.1073\/pnas.0704940104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1129_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1196\/annals.1339.018","volume":"1059","author":"SA Abdulkadir","year":"2005","unstructured":"Abdulkadir SA: Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1. Ann N Y Acad Sci. 2005, 1059: 33-40. 10.1196\/annals.1339.018","journal-title":"Ann N Y Acad Sci"},{"key":"1129_CR60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","volume":"4","author":"K Ellwood-Yen","year":"2003","unstructured":"Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV, Sawyers CL: Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell. 2003, 4: 223-238. 10.1016\/S1535-6108(03)00197-1","journal-title":"Cancer Cell"},{"key":"1129_CR61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1535-6108(03)00141-7","volume":"3","author":"HA Sikder","year":"2003","unstructured":"Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM: Id proteins in cell growth and tumorigenesis. Cancer Cell. 2003, 3: 525-530. 10.1016\/S1535-6108(03)00141-7","journal-title":"Cancer Cell"},{"key":"1129_CR62","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2478\/s11658-010-0007-3","volume":"15","author":"M Schmidt","year":"2010","unstructured":"Schmidt M, Asirvatham AJ, Chaudhary J: Inhibitor of differentiation 1 (ID1) promotes cell survival and proliferation of prostate epithelial cells. Cell Mol Biol Lett. 2010, 15: 272-295. 10.2478\/s11658-010-0007-3","journal-title":"Cell Mol Biol Lett"},{"key":"1129_CR63","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1210\/en.2005-0942","volume":"147","author":"AJ Asirvatham","year":"2006","unstructured":"Asirvatham AJ, Schmidt M, Gao B, Chaudhary J: Androgens regulate the immune\/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells. Endocrinology. 2006, 147: 257-271.","journal-title":"Endocrinology"},{"key":"1129_CR64","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/nn.2646","volume":"13","author":"CE Scott","year":"2010","unstructured":"Scott CE, Wynn SL, Sesay A, Cruz C, Cheung M, Gomez Gaviro MV, Booth S, Gao B, Cheah KS, Lovell-Badge R, Briscoe J: SOX9 induces and maintains neural stem cells. Nat Neurosci. 2010, 13: 1181-1189. 10.1038\/nn.2646","journal-title":"Nat Neurosci"},{"key":"1129_CR65","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0002-9440(10)64814-6","volume":"157","author":"S Signoretti","year":"2000","unstructured":"Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, Yang A, Montironi R, McKeon F, Loda M: p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000, 157: 1769-1775. 10.1016\/S0002-9440(10)64814-6","journal-title":"Am J Pathol"},{"key":"1129_CR66","doi-asserted-by":"publisher","first-page":"e5722","DOI":"10.1371\/journal.pone.0005722","volume":"4","author":"R Blum","year":"2009","unstructured":"Blum R, Gupta R, Burger PE, Ontiveros CS, Salm SN, Xiong X, Kamb A, Wesche H, Marshall L, Cutler G: Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer. PLoS One. 2009, 4: e5722- 10.1371\/journal.pone.0005722","journal-title":"PLoS One"},{"key":"1129_CR67","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1101\/gad.1395006","volume":"20","author":"ML Chen","year":"2006","unstructured":"Chen ML, Xu PZ, Peng XD, Chen WS, Guzman G, Yang X, Di Cristofano A, Pandolfi PP, Hay N: The deficiency of Akt1 is sufficient to suppress tumor development in Pten+\/- mice. Genes Dev. 2006, 20: 1569-1574. 10.1101\/gad.1395006","journal-title":"Genes Dev"},{"key":"1129_CR68","doi-asserted-by":"publisher","first-page":"e17449","DOI":"10.1371\/journal.pone.0017449","volume":"6","author":"NJ Clegg","year":"2011","unstructured":"Clegg NJ, Couto SS, Wongvipat J, Hieronymus H, Carver BS, Taylor BS, Ellwood-Yen K, Gerald WL, Sander C, Sawyers CL: MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors. PLoS One. 2011, 6: e17449- 10.1371\/journal.pone.0017449","journal-title":"PLoS One"},{"key":"1129_CR69","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1101\/gad.913901","volume":"15","author":"WS Chen","year":"2001","unstructured":"Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K: Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 2001, 15: 2203-2208. 10.1101\/gad.913901","journal-title":"Genes Dev"},{"key":"1129_CR70","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1432-0436.2008.00277.x","volume":"76","author":"GS Prins","year":"2008","unstructured":"Prins GS, Putz O: Molecular signaling pathways that regulate prostate gland development. Differentiation. 2008, 76: 641-659. 10.1111\/j.1432-0436.2008.00277.x","journal-title":"Differentiation"},{"key":"1129_CR71","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ydbio.2005.02.001","volume":"280","author":"L Bedford","year":"2005","unstructured":"Bedford L, Walker R, Kondo T, van Cruchten I, King ER, Sablitzky F: Id4 is required for the correct timing of neural differentiation. Dev Biol. 2005, 280: 386-395. 10.1016\/j.ydbio.2005.02.001","journal-title":"Dev Biol"},{"key":"1129_CR72","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/nprot.2011.406","volume":"6","author":"M Fanelli","year":"2011","unstructured":"Fanelli M, Amatori S, Barozzi I, Minucci S: Chromatin immunoprecipitation and high-throughput sequencing from paraffin-embedded pathology tissue. Nat Protoc. 2011, 6: 1905-1919. 10.1038\/nprot.2011.406","journal-title":"Nat Protoc"},{"key":"1129_CR73","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1210\/me.2005-0324","volume":"20","author":"HG Yoon","year":"2006","unstructured":"Yoon HG, Wong J: The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. Mol Endocrinol. 2006, 20: 1048-1060. 10.1210\/me.2005-0324","journal-title":"Mol Endocrinol"},{"key":"1129_CR74","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nat Meth. 2012, 9: 671-675. 10.1038\/nmeth.2089. 10.1038\/nmeth.2089","journal-title":"Nat Meth"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-12-67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:21:14Z","timestamp":1630542074000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-12-67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,21]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-12-67","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,21]]},"assertion":[{"value":"4 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"67"}}